A Novel Synthesized Tyrosinase Inhibitor, (E)-3-(4-hydroxybenzylidene) chroman-4-one (MHY1294) Inhibits α-MSH-induced Melanogenesis in B16F10 Melanoma Cells |
Jeon, Hyeyoung
(College of Pharmacy, Pusan National University)
Lee, Seulah (College of Pharmacy, Pusan National University) Yang, Seonguk (College of Pharmacy, Pusan National University) Bang, EunJin (College of Pharmacy, Pusan National University) Ryu, Il Young (College of Pharmacy, Pusan National University) Park, Yujin (College of Pharmacy, Pusan National University) Jung, Hee Jin (College of Pharmacy, Pusan National University) Chung, Hae Young (College of Pharmacy, Pusan National University) Moon, Hyung Ryong (College of Pharmacy, Pusan National University) Lee, Jaewon (College of Pharmacy, Pusan National University) |
1 | Bilodeau, M. L., Greulich, J. D., Hullinger, R. L., Bertolotto, C., Ballotti, R. and Andrisani, O. M. 2001. BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes. Pigment Cell Res. 14, 328-336. DOI |
2 | Brenner, M. and Hearing, V. J. 2008. The protective role of melanin against UV damage in human skin. Photochem. Photobiol. 84, 539-549. DOI |
3 | Chen, W. C., Tseng, T. S., Hsiao, N. W., Lin, Y. L., Wen, Z. H., Tsai, C. C., Lee, Y. C., Lin, H. H. and Tsai, K. C. 2015. Discovery of highly potent tyrosinase inhibitor, T1, with significant anti-melanogenesis ability by zebrafish in vivo assay and computational molecular modeling. Sci. Rep. 5, 7995. DOI |
4 | Halaban, R., Pomerantz, S. H., Marshall, S. and Lerner, A. B. 1984. Tyrosinase activity and abundance in Cloudman melanoma cells. Arch. Biochem. Biophys. 230, 383-387. DOI |
5 | Desideri, N., Bolasco, A., Fioravanti, R., Monaco, L. P., Orallo, F., Yanez, M., Ortuso, F. and Alcaro, S. 2011. Homoisoflavonoids: Natural scaffolds with potent and selective monoamine oxidase-B inhibition properties. J. Med. Chem. 54, 2155-2164. DOI |
6 | Lee, S. E., Park, S. H., Oh, S. W., Yoo, J. A., Kwon, K., Park, S. J., Kim, J., Lee, H. S., Cho, J. Y. and Lee, J. 2018. Beauvericin inhibits melanogenesis by regulating cAMP/PKA/CREB and LXR-α/p38 MAPK-mediated pathways. Sci. Rep. 8, 1-12. |
7 | Hu, Z. M., Zhou, Q., Lei, T. C., Ding, S. F. and Xu, S. Z. 2009. Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: Biosafety as skin whitening agents. J. Dermatol. Sci. 55, 179-184. DOI |
8 | Hunt, G., Todd, C., Cresswell, J. E. and Thody, A. J. 1994. Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J. Cell. Sci. 107, 205-211. DOI |
9 | Jung, H. J., Noh, S. G., Park, Y., Kang, D., Chun, P., Chung, H. Y. and Moon, H. R. 2019. In vitro and in silico insights into tyrosinase inhibitors with (E)-benzylidene-1-indanone derivatives. Comput. Struct. Biotechnol. J. 17, 1255-1264. DOI |
10 | Kang, S. J., Choi, B. R., Lee, E. K., Kim, S. H., Yi, H. Y., Park, H. R., Song, C. H., Lee, Y. J. and Ku, S. K. 2015. Inhibitory effect of dried pomegranate concentration powder on melanogenesis in B16F10 melanoma cells; involvement of p38 and PKA signaling pathways. Int. J. Mol. Sci. 16, 24219-24242. DOI |
11 | Suwannarach, N., Kumla, J., Watanabe, B., Matsui, K. and Lumyong, S. 2019. Characterization of melanin and optimal conditions for pigment production by an endophytic fungus, Spissiomyces endophytica SDBR-CMU319. PloS One 14, e0222187. DOI |
12 | Kim, A., Yim, N. H., Im, M., Jung, Y. P., Liang, C., Cho, W. K. and Ma, J. Y. 2013. Ssanghwatang, an oriental herbal cocktail, exerts anti-melanogenic activity by suppression of the p38 MAPK and PKA signaling pathways in B16F10 cells. BMC. Complement. Altern. Med. 13, 214. DOI |
13 | Oh, T. I., Yun, J. M., Park, E. J., Kim, Y. S., Lee, Y. M. and Lim, J. H. 2017. Plumbagin suppresses α-MSH-induced melanogenesis in B16F10 mouse melanoma cells by inhibiting tyrosinase activity. Int. J. Mol. Sci. 18, 320. DOI |
14 | Wolber, G. and Langer, T. 2005. LigandScout: 3-D Pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 45, 160-169. DOI |
15 | Parvez, S., Kang, M., Chung, H. S., Cho, C., Hong, M. C., Shin, M. K. and Bae, H. 2006. Survey and mechanism of skin depigmenting and lightening agents. Phytother. Res. 20, 921-934. DOI |
16 | Petit, L. and Pierard, G. 2003. Skin lightening products revisited. Int. J. Cosmet. Sci. 25, 169-181. DOI |
17 | Vogeli, U., von Philipsborn, W., Nagarajan, K. and Nair, M. D. 1978. Structure of addition products of acetylenedicarboxylic acid esters with various dinucleophiles. An application of C, H-spin-coupling constants. Helvetica. Chimica. Acta. 61, 607-617. DOI |
18 | O'Donoghue, J. L. 2006. Hydroquinone and its analogues in dermatology-a risk benefit viewpoint. J. Cosmet. Dermatol. 5, 196-203. DOI |
19 | Kim, S. H., Ha, Y. M., Moon, K. M., Choi, Y. J., Park, Y. J., Jeong, H. O., Chung, K. W., Lee, H. J., Chun, P. and Moon, H. R. 2013. Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor. Arch. Pharm. Res. 36, 1189-1197. DOI |
20 | Yoshino, M. and Murakami, K. 2009. A graphical method for determining inhibition constants. J. Enzyme Inhib. Med. Chem. 24, 1288-1290. DOI |
21 | Ko, G. A. and Kim Cho, S. 2018. Ethyl linoleate inhibits α-MSH-induced melanogenesis through Akt/GSK3β/β-catenin signal pathway. Kor. J. Physiol. Pharmacol. 22, 53-61. DOI |
22 | Kim, C. S., Noh, S. G., Park, Y., Kang, D., Chun, P., Chung, H. Y., Jung, H. J. and Moon, H. R. 2018. A potent tyrosinase inhibitor,(E)-3-(2, 4-dihydroxyphenyl)-1-(thiophen-2-yl) prop2-en-1-one, with anti-melanogenesis properties in α-MSH and IBMX-induced B16F10 melanoma cells. Molecules 23, 2725. DOI |
23 | Kim, H. R., Lee, H. J., Choi, Y. J., Park, Y. J., Woo, Y., Kim, S. J., Park, M. H., Lee, H. W., Chun, P., Chung, H. Y. and Moon, H. R. 2014. Benzylidene-linked thiohydantoin derivatives as inhibitors of tyrosinase and melanogenesis: importance of the β-phenyl-α,β-unsaturated carbonyl functionality. Med. Chem. Commun. 5, 1410. DOI |
24 | No, J. K., Kim, Y. J., Shim, K. H., Jun, Y. S., Rhee, S. H., Yokozawa, T. and Chung, H. Y. 1999. Inhibition of tyrosinase by green tea components. Life Sci. 65, PL241-PL246. |
25 | Lim, J. W., Ha, J. H., Jeong, Y. J. and Park, S. N. 2018. Anti-melanogenesis effect of dehydroglyasperin C through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16F1 melanoma cells. Pharmacol. Rep. 70, 930-935. DOI |
26 | Lajis, A. F., Hamid, M. and Ariff, A. B. 2012. Depigmenting effect of kojic acid esters in hyperpigmented B16F1 melanoma cells. J. Biomed. Biotechnol. 2012, doi:10.1155/2012/952452. DOI |
27 | Liu, Q. H., Wu, J. J., Li, F., Cai, P., Yang, X. L., Kong, L. Y. and Wang, X. B. 2017. Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease. Med. Chem. Commun. 8, 1459-1467. DOI |
28 | Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K. and Olson, A. J. 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639-1662. DOI |
29 | Moustakas, D. T., Lang, P. T., Pegg, S., Pettersen, E., Kuntz, I. D., Brooijmans, N. and Rizzo, R. C. 2006. Development and validation of a modular, extensible docking program: DOCK 5. J. Comput. Aided. Mol. Des. 20, 601-619. DOI |
30 | Alam, M. B., Ahmed, A., Motin, M. A., Kim, S. and Lee, S. H. 2018. Attenuation of melanogenesis by Nymphaea nouchali (Burm. f) flower extract through the regulation of cAMP/ CREB/MAPKs/MITF and proteasomal degradation of tyrosinase. Sci. Rep. 8, 1-14. |
31 | Arndt, K. A. and Fitzpatrick, T. B. 1965. Topical use of hydroquinone as a depigmenting agent. JAMA. 194, 965-967. DOI |
32 | Balcos, M. C., Kim, S. Y., Jeong, H. S., Yun, H. Y., Baek, K. J., Kwon, N. S., Park, K. C. and Kim, D. S. 2014. Docosahexaenoic acid inhibits melanin synthesis in murine melanoma cells in vitro through increasing tyrosinase degradation. Acta. Pharmacol. Sin. 35, 489-495. DOI |
33 | Bang, E., Noh, S. G., Ha, S., Jung, H. J., Kim, D. H., Lee, A. K., Hyun, M. K., Kang, D., Lee, S. and Park, C. 2018. Evaluation of the novel synthetic tyrosinase inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene) thiochroman-4-one (MHY 1498) in vitro and in silico. Molecules 23, 3307. DOI |